Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine versus intravenous morphine sulfate versus intravenous ketorolac for pain relief in renal colic
IRCT20230718058838N1Phase 4Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in Renal colic comparing Intranasal ketamine, Intravenous morphine sulfate and Intravenous ketorolac (3 arms). Primary endpoint: Pain intensity based on Visual Analogue Scale at 60 minutes. Started Aug 2023; status: completed.
02
Drugs
ketaminemorphineketorolac
03
Conditions
Renal colic
Beyond the preview
Go deeper on IRCT20230718058838N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230718058838N1.